News & Perspective

Dec 31, 2012

Dec 31, 2012

FDA approves first med for multidrug-resistant TB

(CIDRAP News) – The US Food and Drug Administration (FDA) today announced its approval of Sirturo (bedaquiline), the first drug developed specifically to treat multidrug-resistant tuberculosis (MDR-TB), saying it must be used in combination with other TB medications.

Dec 20, 2012

Dec 20, 2012

Attack rate in fungal meningitis outbreak estimated at 4.4%

(CIDRAP News) – Researchers estimate from preliminary data that 4.4% of patients who were exposed to contaminated steroid drugs from a Massachusetts compounding pharmacy contracted fungal meningitis or other fungal infections, according to a new report in the New England Journal of Medicine.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»